UK markets closed

Sanofi (SNYNF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
95.500.00 (0.00%)
As of 01:02PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close95.50
Open95.50
Bid96.21 x 45100
Ask101.21 x 45100
Day's range95.50 - 95.50
52-week range86.12 - 110.16
Volume100
Avg. volume12,398
Market cap121.387B
Beta (5Y monthly)0.41
PE ratio (TTM)24.61
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield4.07 (4.26%)
Ex-dividend date13 May 2024
1y target estN/A
  • Zacks

    Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD

    Eli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi (SNY) and Regeneron's Dupixent gets approval for COPD in Europe.

  • Reuters

    Bpifrance eyes investment in Sanofi's consumer health business

    The French public investment bank is in talks with "many funds" and may team up with the winning bidder for Sanofi's consumer health unit, Gonzalo was quoted as saying. Bpifrance confirmed Gonzalo had made the comments on Sanofi's consumer health unit and other potential investments during a briefing on Thursday.

  • Bloomberg

    French State Investment Firm Eyes Stake in Sanofi Consumer Unit

    (Bloomberg) -- Bpifrance SACA is looking at a potential investment in Sanofi SA’s consumer health unit as it eyes bigger health investments, according to its executive director Jose Gonzalo.Most Read from BloombergBiden’s Fourth of July Shrouded by Pressure to Drop 2024 BidKamala Harris Is Having a Surprise Resurgence as Biden’s Campaign UnravelsSingapore Couples Are Marrying Earlier to Buy Homes, Leading Some to RegretNewsom Shocks California Politics by Scrapping Crime MeasureHouse Democrats C